{"id":"W3092982314","doi":"10.1101/2020.10.15.20209817","title":"Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results","year":2020,"lang":"en","type":"preprint","venue":"medRxiv","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":635,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lopinavir; Medicine; Hydroxychloroquine; Lopinavir/ritonavir; Randomized controlled trial; Ritonavir; Internal medicine; Relative risk; Coronavirus disease 2019 (COVID-19); Confidence interval; Virology; Viral load; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004898161,0.0006733965,0.002350132,0.0002659973,0.0002746213,0.0001291248,0.0008856723,0.0006972303,0.00007316824],"category_scores_gemma":[0.3390047,0.0005731842,0.001342521,0.0003238523,0.0006325173,0.00005907373,0.003050138,0.00241964,0.00008387227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006665734,"about_ca_system_score_gemma":0.004056539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003473017,"about_ca_topic_score_gemma":0.00004144364,"domain_scores_codex":[0.9931005,0.0005560267,0.001846616,0.002202081,0.001361673,0.0009331107],"domain_scores_gemma":[0.9814563,0.0138043,0.0007499206,0.00207338,0.0005803123,0.00133582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.7792976,0.00188306,0.005066872,0.02091364,0.002587558,0.001133319,0.006361052,0.00004867586,0.002017291,0.0005917994,0.1673227,0.01277644],"study_design_scores_gemma":[0.1773958,0.005910289,0.003730751,0.00119088,0.0008531107,0.00000157177,0.0001750996,0.004464973,0.001356504,0.009516136,0.7943024,0.001102514],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.4247043,0.0005431887,0.01553627,0.508866,0.00649134,0.02760374,0.004317127,0.001640286,0.01029781],"genre_scores_gemma":[0.9761432,0.0007603457,0.001122239,0.01207295,0.003810908,0.00107318,0.000489452,0.000119864,0.004407872],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6269797,"threshold_uncertainty_score":0.9998818,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1918127409737904,"score_gpt":0.4902112159353825,"score_spread":0.2983984749615922,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}